2-(3-bromo-propoxy)-1,4-difluoro-benzene | 857276-92-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-(3-bromo-propoxy)-1,4-difluoro-benzene
• 英文别名: 2-(3-bromopropoxy)-1,4-difluorobenzene
• CAS: 857276-92-7
• 化学式: C₉H₉BrF₂O
• 分子量: 251.071
• InChiKey: XVDMRLUZDUUXJV-UHFFFAOYSA-N

物化性质

• 沸点：
  268.0±30.0 °C(Predicted)
• 密度：
  1.494±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(3-bromo-propoxy)-1,4-difluoro-benzene 、 8-氟-1,3,4,5-四氢-2H-吡啶基-[4,3-b]吲哚-2-羧酸乙酯 在 potassium hydroxide 作用下， 以 二甲基亚砜 为溶剂， 反应 0.25h， 生成
  参考文献：
  名称：

  Novel Carboline Derivatives as Potent Antifungal Lead Compounds: Design, Synthesis, and Biological Evaluation

  摘要：

  A series of novel antifungal carboline derivatives was designed and synthesized, which showed broad-spectrum antifungal activity. Particularly, compound C38 showed comparable in vitro antifungal activity to fluconazole without toxicity to human embryonic lung cells. It also exhibited good fungicidal activity against both fluconazole-sensitive and -resistant Candida albicans cells and had potent inhibition activity against Candida albicans biofilm formation and hyphal growth. Moreover, C38 showed good synergistic antifungal activity in combination with fluconazole (FLC) against FLC-resistant Candida species. Preliminary mechanism studies revealed that C38 might act by inhibiting the synthesis of fungal cell wall.

  DOI：

  10.1021/ml400492t
• 作为产物：
  描述：

  2,5-二氟苯酚 、 1,3-二溴丙烷 生成 2-(3-bromo-propoxy)-1,4-difluoro-benzene
  参考文献：
  名称：

  Organic compounds

  摘要：

  本发明涉及一种一般式（I）和（II）的替代哌啶化合物，其中所述的取代基定义在说明书中有详细解释。该化合物特别适用于作为肾素抑制剂，并且具有高度的药效。

  公开号：

  US07790715B2

文献信息

• 3,4,5-Substituted piperidines as therapeutic compounds
  申请人：Herold Peter

  公开号：US20070167433A1

  公开（公告）日：2007-07-19

  Use of compounds of the general formula (I) and pharmaceutically acceptable salt thereof, in which R 1 , R 2 , R 3 , R 4 , W, X and Z, n and m have the definitions illustrated in detail in the description, as beta-secretase, cathepsin D, plasmepsin II and/or HIV protease inhibitors.

  在一般式（I）及其药用可接受盐中使用具有详细定义的R1、R2、R3、R4、W、X和Z、n和m的化合物，作为β-分泌酶、半胱氨酸蛋白酶D、质粒蛋白酶II和/或HIV蛋白酶抑制剂。
• [EN] ORGANIC COMPOUNDS<br/>[FR] COMPOSES ORGANIQUES
  申请人：SPEEDEL EXPERIMENTA AG

  公开号：WO2005061457A1

  公开（公告）日：2005-07-07

  Novel substituted piperidines of the general formulae (I) and (II) with the substituent definitions as explained in detail in the description are described. The compounds are suitable in particular as renin inhibitors and are highly potent.

  描述了一种具有一般式(I)和(II)的新型替代哌啶化合物，其中详细说明了取代基定义。这些化合物特别适用作为肾素抑制剂，并且具有很高的效力。
• [EN] NOVEL OXABISPIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS<br/>[FR] NOUVEAUX COMPOSES OXABISPIDINE ET LEUR UTILISATION DANS LE TRAITEMENT DES ARYTHMIES CARDIAQUES
  申请人：ASTRAZENECA AB

  公开号：WO2005123748A1

  公开（公告）日：2005-12-29

  There is provided compounds of formula (I), wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

  提供了式（I）的化合物，其中R1、R2、R3、R4、R41至R46、A、B和G的含义如描述中所述，这些化合物对预防和治疗心律失常，特别是心房和心室心律失常，具有实用价值。
• Organic compounds
  申请人：Herold Peter

  公开号：US20090012055A1

  公开（公告）日：2009-01-08

  Novel substituted piperidines of the general formulae (I) and (II) with the substituent definitions as explained in detail in the description are described. The compounds are suitable in particular as renin inhibitors and are highly potent.

  描述了一种通式为(I)和(II)的新型替代哌啶，其中所述的取代基定义在详细说明中。这些化合物特别适用于作为肾素抑制剂，并且具有高度的效力。
• Novel Oxabispidine Compounds and Their Use in the Treatment of Cardiac Arrhythmias
  申请人：Bjore Annika

  公开号：US20090005558A1

  公开（公告）日：2009-01-01

  There is provided compounds of formula (I), wherein R 1 , R 2 , R 3 , R 4 , R 41 to R 46 , A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

  提供了式(I)的化合物，其中R1、R2、R3、R4、R41至R46、A、B和G的含义在说明中给出，这些化合物在预防和治疗心律失常方面是有用的，尤其是房性和室性心律失常。